Bal Pharma Limited has issued a notice for a postal ballot to seek shareholder approval for a preferential issue of warrants to a promoter. The disclosure is made pursuant to Regulations 30 and 44 of the SEBI Listing Regulations.
Nature of the Event
The company is seeking shareholder approval through a postal ballot (electronic voting) for a special resolution to issue 10,00,000 convertible warrants to Mr. Shailesh Siroya, a promoter, on a preferential basis.
Key Quantitative Figures
- Number of Warrants: 10,00,000
- Issue Price per Warrant: ₹81 (including a premium of ₹71)
- Total Issue Size: ₹8,10,00,000
- Relevant Date for Pricing: July 09, 2026
- Minimum Price as per SEBI ICDR: ₹80.14 per warrant
- Initial Payment: 25% of total consideration (₹20.25 per warrant) payable on allotment
- Balance Payment: 75% (₹60.75 per warrant) payable before conversion
- Conversion Period: 18 months from date of allotment
- Post-Issue Promoter Holding Increase: From 50.85% to 53.76% (on full conversion)
- Specific Allottee Holding Increase: Mr. Shailesh Siroya's holding would increase from 17.24% to 22.13%
Dates and Timeline
- Cut-off Date for Voting Rights: July 03, 2026
- E-voting Period: July 10, 2026 (9:00 AM IST) to August 08, 2026 (5:00 PM IST)
- Result Declaration: On or before August 11, 2026
- Warrant Allotment Timeline: Within 15 days of shareholder approval
- Board Approval Date: May 27, 2026
Parties Involved
- Proposed Allottee: Mr. Shailesh Siroya (Promoter)
- Scrutinizer: Mr. Parameshwar Bhat, Practicing Company Secretary (Membership No. 11004)
- E-voting Service Provider: National Securities Depository Limited (NSDL)
- Company Secretary: Shreepada ML (ICSI Membership No. A66681)
Purpose and Rationale
The funds raised (₹8.10 crore) will be used to part-finance a greenfield project for setting up an API manufacturing facility at Yadgir, Karnataka. The company has already acquired 5 acres of land at this location and obtained environmental clearance from the Ministry of Forest & Environment.
Financial and Operational Impact
The preferential issue will increase the company's paid-up equity capital from 1,59,20,872 shares to 1,69,20,872 shares upon full conversion of all warrants. The promoter holding will increase from 50.85% to 53.76%, while public holding will decrease from 49.15% to 46.24%.
Capital Structure Impact
The issue will result in dilution of approximately 5.88% to existing shareholders upon full conversion of all warrants. The resulting equity shares will rank pari-passu with existing equity shares in all respects including dividend and voting rights.
Special Conditions and Lock-in
- Warrants and resulting equity shares are subject to lock-in as per Regulation 167 of SEBI ICDR Regulations
- Warrants cannot be sold, transferred, hypothecated or encumbered during lock-in period
- If warrants are not converted within 18 months, the amount paid will be forfeited
- The company must ensure compliance with minimum public shareholding norms
Voting Process Details
The company has appointed NSDL to facilitate remote e-voting. Members as of July 03, 2026 cut-off date can vote electronically. Institutional shareholders must send scanned copies of board resolutions/authority letters to the scrutinizer. The scrutinizer will submit a report to the managing director or authorized director, and results will be announced by August 11, 2026.